Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma

authors

Clement Paul M.J.
Dirven Linda
Eoli Marica
Sepulveda-Sanchez Juan
Walenkamp Annemiek M.E.
Frenel Jean
Franceschi Enrico
Weller Michael
Chinot Olivier
de Vos Filip Y.F.L.
Whenham Nicolas
Sanghera Paul
Looman Jim
Kundu Madan
Peter de Geus Jan
Nuyens Sarah
Spruyt Maarten
Gorlia Thierry
Coens Corneel
Golfinopoulos Vassilis
Reijneveld Jaap
van den Bent Martin

document type

ART

more information